StopDownOpen the app

New fund · Healthcare & Life Sciences

HealthQuad raises ₹550 crore in first close of Fund III to back Indian healthcare startups

By ·

Date
Company
HealthQuad
What it does
healthcare venture capital firm
Kind
New fund
Amount
₹550 Cr
Founded
2016
Sector
Healthcare & Life Sciences

What they do

HealthQuad is a healthcare venture capital firm that invests in early-growth companies across healthtech, medtech, biopharma technology, and new healthcare…

What happened

HealthQuad Fund III has raised ₹550 crore in its first close, with a target of ₹1,700 crore and a greenshoe option that could increase the total to ₹2,500 crore

Why it matters

The fund focuses on India, with a discretionary share for Southeast Asia, and has already invested in LifeSigns, an AI-powered remote patient monitoring…

The details

  • HealthQuad, a healthcare venture capital firm backed by Quadria Group, has raised ₹550 crore in the first close of its third fund, HealthQuad Fund III.
  • The fund targets ₹1,700 crore with a greenshoe option that could increase the total to ₹2,500 crore.
  • The commitments have come from existing investors in HealthQuad’s earlier funds, as well as new limited partners, including local and global funds of funds, institutions, and family offices.
  • The fund has already made its first investment in LifeSigns, an AI-powered remote patient monitoring platform.
  • HealthQuad Fund III is managed by HealthQuad Advisors Private Limited, a vehicle 100% owned by Quadria Group.
  • Following the mutual separation between KOIS and Quadria Group in 2025, Quadria Group retained a majority of the team managing HealthQuad’s prior funds and expanded its leadership with the addition of Rahul Agarwal and Namit Chugh.
  • HealthQuad was founded in 2016 as Quadria’s early-growth vehicle for technology-led healthcare companies.
  • Its portfolio includes Qure.ai, Wysa, Redcliffe Labs, GoApptiv, CureSkin, Strand Life Sciences, THB, ekincare, and Medikabazaar.

The bigger picture

  • HealthQuad Fund III targets 13-15 healthtech startups across AI-driven healthcare, digital therapeutics, ambulatory care, enterprise SaaS, and point-of-care devices.
  • The fund focuses on India, with a discretionary share for other markets in Southeast Asia.
  • HealthQuad’s earlier two funds had backed 18 healthtech startups, including GoApptiv, Qure.ai, Redcliffe Labs, CureSkin, Strand Life Sciences, Medikabazaar, THB, Wysa, and ekincare.
  • The Indian healthtech segment has a track record of strong innovations but has lacked institutional backing.

About the business

  • HealthQuad is a healthcare venture capital firm that invests in early-growth companies across healthtech, medtech, biopharma technology, and new healthcare delivery models.
  • The firm focuses on India, with a discretionary share for Southeast Asia.
  • HealthQuad Fund III targets 13-15 healthtech startups across AI-driven healthcare, digital therapeutics, ambulatory care, enterprise SaaS, and point-of-care devices.
  • The fund has already invested in LifeSigns, an AI-powered remote patient monitoring platform.
  • HealthQuad was founded in 2016 as Quadria’s early-growth vehicle for technology-led healthcare companies.
  • Its portfolio includes Qure.ai, Wysa, Redcliffe Labs, GoApptiv, CureSkin, Strand Life Sciences, THB, ekincare, and Medikabazaar.

What happens next

  • HealthQuad Fund III will continue to support healthcare startups focused on improving access, affordability, and quality of care through technology, business model innovation, and product development.

The deal

Type
fund

Investors

  • existing investors (existing) — existing limited partners in HealthQuad’s earlier funds
  • new limited partners (participated) — local and global funds of funds, institutions, and family offices

Founders

  • Amit Varma, key person
  • Abrar Mir, key person
  • Sunil Thakur, Co-founder and IC Member
  • Rahul Agarwal, Partner and IC Member
  • Namit Chugh, added to leadership

Other articles talking about it

Read it as a card in the app

Same day

All startup news on 19 June 2026 →